Research & Development

色姐妹综合网亚州性夜夜射色大姐综合网 色天使在线男子跟踪骚扰晨跑美女 没想对方是退伍女兵反被追


  眾人紛紛解囊,不一會,桌子上就多了百余枚雲錢。   如“富與貴,人之所欲也”,色姐妹综合网   張湯點點頭,然後再次拱手面對皇城位置再次問道︰“雲瑯,你真的要將西北理工典籍公諸于世麼?”亚州性夜夜射   大長秋哈哈哈大笑道︰“貴人怎麼起了這樣奇怪的心思?區區幾條魚罷了。”   正在喝酒的霍去病附和的點點頭道︰“是啊,白登山的狀況雖然險惡,卻沒有那麼危險,不算什麼。”色大姐综合网 色天使在线   雲瑯相信真正祝賀他新婚的人,只有自家的僕婦,工匠,門客,再就是算上霍去病,曹襄,李敢幾個人。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo